| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Applied and Environmental Microbiology, May 2007, p. 3391-3403, Vol. 73, No. 10
0099-2240/07/$08.00+0 doi:10.1128/AEM.02625-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Groupe de Génétique des Biofilms, CNRS URA 2172, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris Cedex 15, France
Received 10 November 2006/ Accepted 15 March 2007
Despite the economic and sanitary problems caused by harmful biofilms, biofilms are nonetheless used empirically in industrial environmental and bioremediation processes and may be of potential use in medical settings for interfering with pathogen development. Escherichia coli is one of the bacteria with which biofilm formation has been studied in great detail, and it is especially appreciated for biotechnology applications because of its genetic amenability. Here we describe the development of two new genetic tools enabling the constitutive and inducible expression of any gene or operon of interest at its native locus. In addition to providing valuable tools for complementation and overexpression experiments, these two compact genetic cassettes were used to modulate the biofilm formation capacities of E. coli by taking control of two biofilm-promoting factors, autotransported antigen 43 adhesin and the bscABZC cellulose operon. The modulation of the biofilm formation capacities of E. coli or those of other bacteria capable of being genetically manipulated may be of use both for reducing and for improving the impact of biofilms in a number of industrial and medical applications.
Published ahead of print on 23 March 2007.
Supplemental material for this article may be found at http://aem.asm.org/.
This article has been cited by other articles:
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|